TEF-1 transcription factors regulate activity of the mouse mammary tumor virus LTR

Biochemical and Biophysical Research Communications

Volumn 296, Issue 5, 2002, Pages 1279-1285

  Maeda, Tomoji ^a   Maeda, Mamiko ^a   Stewart, Alexandre F R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; DTEF 1; ETF; Glucocorticoid; LTR; MMTV; RTEF 1; TEF 1

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DTEF 1; TRANSCRIPTION FACTOR ETF; TRANSCRIPTION FACTOR RTEF 1; TRANSCRIPTION FACTOR TEF 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REGULATORY MECHANISM; TRANSCRIPTION INITIATION;

BASE SEQUENCE; BINDING SITES; CELL LINE; DEXAMETHASONE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, VIRAL; GLUCOCORTICOIDS; HUMANS; MAMMARY TUMOR VIRUS, MOUSE; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); TERMINAL REPEAT SEQUENCES; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

ERAGROSTIS TEF; MINK CELL FOCUS-FORMING VIRUS; MOUSE MAMMARY TUMOR VIRUS;

EID: 0036387095     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02085-5     Document Type: Article

References (42)

1. R. Callahan, MMTV-induced mutations in mouse mammary tumors: their potential relevance to human breast cancer, Breast Cancer Res. Treat. 39 (1996) 33-44.
2. Y. Wang, J.F. Holland, I.J. Bleiweiss, S. Melana, X. Liu, I. Pelisson, A. Cantarella, K. Stellrecht, S. Mani, B.G. Pogo, Detection of mammary tumor virus env gene-like sequences in human breast cancer, Cancer Res. 55 (1995) 5173-5179.
3. B. Liu, Y. Wang, S.M. Melana, I. Pelisson, V. Najfeld, J.F. Holland, B.G. Pogo, Identification of a proviral structure in human breast cancer, Cancer Res. 61 (2001) 1754-1759.
4. P. Etkind, J. Du, A. Khan, J. Pillitteri, P.H. Wiernik, Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient, Clin. Cancer Res. 6 (2000) 1273-1278.
5. D. Henrard, S.R. Ross, Endogenous mouse mammary tumor virus is expressed in several organs in addition to the lactating mammary gland, J. Virol. 62 (1988) 3046-3049.
6. P. Lefebvre, D.S. Berard, M.G. Cordingley, G.L. Hager, Two regions of the mouse mammary tumor virus long terminal repeat regulate the activity of its promoter in mammary cell lines, Mol. Cell. Biol. 11 (1991) 2529-2537.
7. E. Mok, T.V. Golovkina, S.R. Ross, A mouse mammary tumor virus mammary gland enhancer confers tissue-specific but not lactation-dependent expression in transgenic mice, J. Virol. 66 (1992) 7529-7532.
8. V.L. Chandler, B.A. Maler, K.R. Yamamoto, DNA sequences bound specifically by glucocorticoid receptor in vitro render a heterologous promoter hormone responsive in vivo, Cell 33 (1983) 489-499.
9. S.R. Ross, C.L. Hsu, Y. Choi, E. Mok, J.P. Dudley, Negative regulation in correct tissue-specific expression of mouse mammary tumor virus in transgenic mice, Mol. Cell. Biol. 10 (1990) 5822-5829.
10. Q. Zhu, J.P. Dudley, CDP binding to multiple sites in the mouse mammary tumor virus long terminal repeat suppresses basal and glucocorticoid-induced transcription, J. Virol. 76 (2002) 2168-2179.
11. S. Li, L. Moy, N. Pittman, G. Shue, B. Aufiero, E.J. Neufeld, N.S. LeLeiko, M.J. Walsh, Transcriptional repression of the cystic fibrosis transmembrane conductance regulator gene, mediated by CCAAT displacement protein/cut homolog, is associated with histone deacetylation, J. Biol. Chem. 274 (1999) 7803-7815.
12. Q. Zhu, K. Gregg, M. Lozano, J. Liu, J.P. Dudley, CDP is a repressor of mouse mammary tumor virus expression in the mammary gland, J. Virol. 74 (2000) 6348-6357.
13. V. Andres, B. Nadal-Ginard, V. Mahdavi, Clox, a mammalian homeobox gene related to Drosophila cut, encodes DNA-binding regulatory proteins differentially expressed during development, Development 116 (1992) 321-334.
14. A.F.R. Stewart, S.B. Larkin, I.K.G. Farrance, J.H. Mar, D.E. Hall, C.P. Ordahl, Muscle-enriched TEF-1 isoforms bind M-CAT elements from muscle-specific promoters and differentially activate transcription, J. Biol. Chem. 269 (1994) 3147-3150.
15. A. Andrianopoulos, W.E. Timberlake, ATTS, a new and conserved DNA binding domain, Plant Cell 3 (1991) 747-748.
16. T.R. Bürglin, The TEA domain: a novel, highly conserved DNA-binding motif, Cell 66 (1991) 11-12.
17. I.K. Farrance, J.H. Mar, C.P. Ordahl, M-CAT binding factor is related to the SV40 enhancer binding factor, TEF-1, J. Biol. Chem. 267 (1992) 17234-17240.
18. J.H. Xiao, I. Davidson, H. Matthes, J.M. Garnier, P. Chambon, Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1, Cell 65 (1991) 551-568.
19. T. Ishiji, M.J. Lace, S. Parkkinen, R.D. Anderson, T.H. Haugen, T.P. Cripe, J.H. Xiao, I. Davidson, P. Chambon, L.P. Turek, Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells, EMBO J. 11 (1992) 2271-2281.
20. B. Belandia, M.G. Parker, Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors, J. Biol. Chem. 275 (2000) 30801-30805.
21. T. Maeda, J.R. Mazzulli, I.K. Farrance, A.F. Stewart, Mouse DTEF-1 (ETFR-1, TEF-5) is a transcriptional activator in α1-adrenergic agonist-stimulated cardiac myocytes, J. Biol. Chem. (2002).
22. 1-adrenergic reactivation of the fetal gene program in cardiac myocytes, Circ. Res. 83 (1998) 43-49.
23. W.T. Lee, O. Prakash, D. Klein, N.H. Sarkar, Structural alterations in the long terminal repeat of an acquired mouse mammary tumor virus provirus in a T-cell leukemia of DBA/2 mice, Virology 159 (1987) 39-48.
24. C.L. Hsu, C. Fabritius, J. Dudley, Mouse mammary tumor virus proviruses in T-cell lymphomas lack a negative regulatory element in the long terminal repeat, J. Virol. 62 (1988) 4644-4652.
25. I. Davidson, C. Fromental, P. Augereau, A. Wildeman, M. Zenke, P. Chambon, Cell-type specific protein binding to the enhancer of simian virus 40 in nuclear extracts, Nature 323 (1986) 544-548.
26. D. Bramblett, C.L. Hsu, M. Lozano, K. Earnest, C. Fabritius, J. Dudley, A redundant nuclear protein binding site contributes to negative regulation of the mouse mammary tumor virus long terminal repeat, J. Virol. 69 (1995) 7868-7876.
27. H. Sugimoto, M. Bakovic, S. Yamashita, D.E. Vance, Identification of transcriptional enhancer factor-4 as a transcriptional modulator of CTP:phosphocholine cytidylyltransferase α, J. Biol. Chem. 276 (2001) 12338-12344.
28. 1-adrenergic induction of the skeletal α-actin promoter during cardiac myocyte hypertrophy. Transcriptional enhancer factor-1 and protein kinase C as conserved transducers of the fetal program in cardiac growth, J. Biol. Chem. 270 (1995) 410-417.
29. K. Hasegawa, S.J. Lee, S.M. Jobe, B.E. Markham, R.N. Kitsis, Cis-acting sequences that mediate induction of β-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction, Circulation 96 (1997) 3943-3953.
30. D.J. Thuerauf, C.C. Glembotski, Differential effects of protein kinase c, ras, and raf-1 kinase on the induction of the cardiac b-type natriuretic peptide gene through a critical promoter-proximal M-CAT element, J. Biol. Chem. 272 (1997) 7464-7472.
31. P. Jacquemin, C. Oury, A. Belayew, J.A. Martial, A TEF-1 binding motif that interacts with a placental protein is important for the transcriptional activity of the hCS-B enhancer, DNA Cell Biol. 13 (1994) 1037-1045.
32. M. Yasunami, K. Suzuki, T. Houtani, T. Sugimoto, H. Ohkubo, Molecular characterization of cDNA encoding a novel protein related to transcriptional enhancer factor-1 from neural precursor cells, J. Biol. Chem. 270 (1995) 18649-18654.
33. A. Azakie, S.B. Larkin, I.K.G. Farrance, G. Grenningloh, C.P. Ordahl, DTEF-1, a novel member of the transcription enhancer factor-1 (TEF-1) multigene family, J. Biol. Chem. 271 (1996) 8260-8265.
34. A.F.R. Stewart, C.W. Richard 3rd, J. Suzow, D. Stephan, S. Weremowicz, C.C. Morton, C.N. Adra, Cloning of human RTEF-1, a transcriptional enhancer factor-1-related gene preferentially expressed in skeletal muscle: evidence for an ancient multigene family, Genomics 37 (1996) 68-76.
35. P. Jacquemin, J.A. Martial, I. Davidson, Human TEF-5 is preferentially expressed in placenta and binds to multiple functional elements of the human chorionic somatomammotropin-B gene enhancer, J. Biol. Chem. 272 (1997) 12928-12937.
36. M.P. Gupta, C.S. Amin, M. Gupta, N. Hay, R. Zak, Transcription enhancer factor 1 interacts with a basic helix-loop-helix zipper protein, Max, for positive regulation of cardiac α-myosin heavy-chain gene expression, Mol. Cell. Biol. 17 (1997) 3924-3936.
37. B. Amati, M.W. Brooks, N. Levy, T.D. Littlewood, G.I. Evan, H. Land, Oncogenic activity of the c-Myc protein requires dimerization with Max, Cell 72 (1993) 233-245.
38. C.M. D'Cruz, E.J. Gunther, R.B. Boxer, J.L. Hartman, L. Sintasath, S.E. Moody, J.D. Cox, S.I. Ha, G.K. Belka, A. Golant, R.D. Cardi5, L.A. Chodosh, c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations, Nat. Med. 7 (2001) 235-239.
39. S.K. Oster, C.S. Ho, E.L. Soucie, L.Z. Penn, The myc oncogene: MarvelouslY Complex, Adv. Cancer Res. 84 (2002) 81-154.
40. A. Vassilev, K.J. Kaneko, H. Shu, Y. Zhao, M.L. DePamphilis, TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm, Genes Dev. 15 (2001) 1229-1241.
41. C.T. Guy, S.K. Muthuswamy, R.D. Cardiff, P. Soriano, W.J. Muller, Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice, Genes Dev. 8 (1994) 23-32.
42. G. Dong, E. Loukinova, Z. Chen, L. Gangi, T.I. Chanturita, E.T. Liu, C. Van Waes, Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-κB signal pathway, Cancer Res. 61 (2001) 4797-4808.